Loading...
You are here:  Home  >  News  >  Business  >  Current Article

Apyx Medical Corporation Reports Preliminary Full Year and Fourth Quarter 2020 Revenue Results

By   /  January 14, 2021  /  Comments Off on Apyx Medical Corporation Reports Preliminary Full Year and Fourth Quarter 2020 Revenue Results

    Print       Email


CLEARWATER, Fla.–()–Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today reported preliminary revenue results for the full year and fourth quarter ended December 31, 2020.

Preliminary Fourth Quarter 2020 Revenue Summary:

  • Total Q4 revenue in a range of approximately $10.9 to $11.3 million, up approximately 30% to 35% year-over-year.

    • Advanced Energy revenue in a range of approximately $9.5 to $9.8 million, up approximately 39% to 43% year-over-year.
    • OEM revenue in a range of approximately $1.35 to…



Click here to view the original article.

    Print       Email

You might also like...

Twist Bioscience to Report Fiscal 2021 First Quarter Financial Results on Thursday, February 4, 2020

Read More →